Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced escherichia coli mastitis

Journal of Veterinary Pharmacology and Therapeutics

Volumn 25, Issue 4, 2002, Pages 251-258

  Rantala, M ^a   Kaartinen, L ^a   Valimaki E ^a   Stryrman, M ^a   Hiekkaranta, M ^a   Niemi, A ^b   Saari, L ^b   Pyorala S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATL VET AND FOOD RES INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DRUG METABOLITE; ENROFLOXACIN; FLUNIXIN MEGLUMINE;

ANIMAL EXPERIMENT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COW; DISEASE SEVERITY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MILK LEVEL; DRUG RESPONSE; ESCHERICHIA COLI; FEMALE; FOLLOW UP; LACTATION; MASTITIS; MILK YIELD; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; TIME;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; CATTLE; CLONIXIN; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MASTITIS, BOVINE; MILK; QUINOLONES; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0036051394     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2002.00411.x     Document Type: Article

References (38)

1. Efficacy of flunixin meglumine for the treatment of endotoxin-induced bovine mastitis
2. Pharmacokinetics of flunixin meglumine in lactating cattle after single and multiple intramuscular and intravenous administrations
3. Pharmacodynamics of antimicrobial agents as a basis for determining dosage regimens
4. Effect of phenylbutazone and flunixin meglumine on acute toxic mastitis in dairy cows
5. Measures taken by veterinarians in Sweden in cases of bovine mastitis
6. Mastitis-causing Escherichia coli: Serum sensitivity and susceptibility to selected antibacterials in milk
7. Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitis
8. Antibiotic therapy in the control of mastitis
9. Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens
10. Pharmacokinetics of flunixin meglumine in the cow
11. Recurrent coliform mastitis in the dairy cow
12. Acute phase response in dairy cows with experimentally induced Escherichia coli mastitis
13. Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: Effect on clinical signs and chemiluminescence of circulating neutrophils
14. Rapid assay for monitoring residues of enrofloxacin in milk and meat tissues by HPLC
15. Cow milk yield and composition before development of Escherichia coli mastitis
16. Evaluation of systemic administration of gentamicin for treatment of coliform mastitis in cows
17. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows
18. Acute coliform mastitis in dairy cows: Endotoxin and biochemical changes in plasma and colony-forming units in milk
19. Severe coliform mastitis in practice: Efficacy of a therapy regimen not including antibiotics
20. Effect of antibiotic induced bacterial clearance in the udder on L-selectin shedding of blood neutrophils in cows with Escherichia coli mastitis
21. Pharmacology of analgesic drugs
22. 2α metabolite concentrations after oral and intravenous administration in heifers
23. Resistance of bacteria to antimicrobials
24. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995)
25. Bovine acute mastitis. Part II. Effect of mastitis pathogen, initial inflammatory reaction and therapy on the outcome of the disease
26. Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows
27. Coliform mastitis caused by Escherichia coli. Klebsiella spp., and Enterobacter aerogenes
28. Determination of flunixin in milk by liquid chromatography with confirmation by gas chromatography/mass spectrometry and selected ion monitoring
29. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli
30. Relationship between in vitro sensitivity of coliform pathogens in the udder and the outcome of treatment for clinical mastitis
31. Bacterial growth, inflammatory cytokine production, and neutrophil recruitment during coliform mastitis in cows within ten days after calving, compared with cows at midlactation
32. Clinical response and antimicrobial residue test results in non-antibiotic treated cows with induced acute coliform mastitis
33. Low somatic cell count: A risk factor for subsequent clinical mastitis in a dairy herd
34. Simultaneous determination of enrofloxacin and its primary metabolite ciprofloxacin in bovine milk and plasma by ion-pairing liquid chromatography
35. Classification of newly calved cows into moderate and severe responders to experimentally induced Escherichia coli mastitis
36. Fluoroquinolones
37. Statistical moments in pharmacokinetics
38. Drug selection and use in mastitis: Systemic vs. local therapy